MARKET

INO

INO

Inovio Pharmaceu
NASDAQ
10.27
-0.10
-0.96%
Opening 11:20 04/24 EDT
OPEN
10.42
PREV CLOSE
10.37
HIGH
10.78
LOW
10.22
VOLUME
88.17K
TURNOVER
0
52 WEEK HIGH
14.75
52 WEEK LOW
3.888
MARKET CAP
266.06M
P/E (TTM)
-1.6854
1D
5D
1M
3M
1Y
5Y
Inovio Pharmaceuticals: Neutral On INO-3107 Amidst Stock Dilution And High Valuation
Inovio Pharmaceuticals, Inc. Specializes in DNA-based immunotherapies for HPV-related conditions, cancer, and infectious diseases. The company's flagship drug, INO-3107, shows promise for treating recurrent respiratory papillomatosis. Inovio is preparing for a BLA in 2024 and has the potential for accelerated FDA approval and a 2025 launch. However, the company faces financial and valuation concerns, with a high valuation multiple and a low cash runway.
Seeking Alpha · 5h ago
Inovio Pharmaceuticals: The Dilution Continues
Inovio Pharmaceuticals, Inc. Has diluted its stock at a 30% discount. The company's latest pipeline candidate, INO-3107, is expected to submit a BLA in the second half of 2024. The potential market size for the drug is $770 million. The stock might be worth a speculative long position at $7.50 or below.
Seeking Alpha · 1d ago
Weekly Report: what happened at INO last week (0415-0419)?
Weekly Report · 2d ago
Why Skillsoft Shares Are Trading Lower By Around 27%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Sk Skillsoft Corp. Shares dipped 26.7% to $6.74 on Tuesday. The company reported mixed fourth-quarter financial results and issued FY25 revenue guidance below estimates. WiSA Technologies, Inc. Shares jumped 85% after the company announced a licensing agreement with an HDTV/PTV brand.
Benzinga · 04/16 18:17
Inovio Pharmaceuticals Stock Is Diving Today: What's Happening?
Inovio Pharmaceuticals Inc. Announced the pricing of a public offering of 2,536,258 shares of its common stock. The company anticipates gross proceeds of approximately $36 million. Inovio is a biotechnology company focused on developing and commercializing DNA medicines.
Benzinga · 04/16 13:29
Why Macatawa Bank Shares Are Trading Higher By Around 37%; Here Are 20 Stocks Moving Premarket
Shares of Macatawa Bank Corporation rose sharply in today’s pre-market trading after the company announced a merger agreement with Wintrust Financial Corporation. Dynatronics Corporation shares rose 69.8% to $0.6301 in pre- market trading. Groupon, Inc. Shares fell 8.9% in today's trading.
Benzinga · 04/16 12:14
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Dynatronics (NASDAQ:DYNT) stock rose 84.9% to $0.69 during Tuesday's pre-market session. The company's market cap rose to $3.3 million. Inovio Pharmaceuticals shares fell 24.3% during the session. Akanda shares increased by 23.0% and BioRestorative Therapies shares moved upwards.
Benzinga · 04/16 12:07
Inovio falls after pricing stock offering
Inovio Pharmaceuticals, Inc. Lost 21% premarket Tuesday. DNA medicine developer priced an underwritten offering of its common stock below its currently traded price. Plymouth Meeting, a Pennsylvania-based biotech, intends to raise $36M in gross proceeds from the offering.
Seeking Alpha · 04/16 11:48
More
About INO
Inovio Pharmaceuticals, Inc. is a clinical-stage biotechnology company. The Company is focused on developing and commercializing deoxyribonucleic acid (DNA) medicines to help treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines pipeline include INO-3107 for HPV-related recurrent respiratory papillomatosis (RRP); INO-3112 for the treatment of HPV-related Oropharyngeal Squamous Cell Carcinoma, or OPSCC; VGX-3100 for the treatment of Anal or Perianal HSIL; INO-5401 for the treatment of Glioblastoma Multiforme (GBM), and INO-5401 for the Treatment of Glioblastoma Multiforme (GBM). Its lead candidate is INO-3107 for the treatment of RRP, a rare and debilitating disease of the respiratory tract caused by HPV infection. Its DNA medicines platform consists of DNA plasmids and its CELLECTRA devices, which are used to deliver the DNA plasmids into the cell. Its CELLECTRA device portfolio consists of two models.

Webull offers Inovio Pharmaceuticals Inc stock information, including NASDAQ: INO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, INO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading INO stock methods without spending real money on the virtual paper trading platform.